Sponsor Pipeline

Nathan Denlinger Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06209619 CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma B-Cell Non-Hodgkin Lymphoma-Recurrent Recruiting
NCT07676877 Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care… Recurrent Diffuse Large B-Cell Lymphoma Not Yet Recruiting
Disease Areas
DLBCL (2) Non-Hodgkin Lymphoma (1) Follicular Lymphoma (1)
Get alerts when Nathan Denlinger's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free